Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.6B | 2.5B | 3.3B | 2.5B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 11M | 13M | 6M | 9M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 13M | 13M | 13M | 14M |
| Other income expense | 4M | 5M | 3M | 4M |
| Pretax income | -128M | 479M | 1.0B | 386M |
| Tax provision | -38M | 74M | 220M | 74M |
| Net income | -90M | 405M | 820M | 312M |
| Basic EPS | -0.6 | 2.6 | 5.3 | 2.0 |
| Diluted EPS | -0.6 | 2.6 | 5.2 | 2.0 |
| Basic average shares | 156.4M | 156.4M | 156.2M | 156.3M |
| Diluted average shares | 156.4M | 158.1M | 157.7M | 157.5M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | -90M | 405M | 820M | 312M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |